Results 301 to 310 of about 4,150,951 (316)

The patient who reports a drug allergy

British medical journal, 2020
### What you need to know What should clinicians do when a patient gives a history of a “drug allergy”? If it really is an allergy—an immunological reaction—or a serious adverse drug reaction (ADR), then patients risk serious harm unless they avoid the ...
R. Ferner, P. McGettigan
semanticscholar   +1 more source

The economics of drug allergy.

Current Opinion in Allergy and Clinical Immunology, 2020
PURPOSE OF REVIEW As drug allergy research aims to inform clinical practice, implementation of best practices may be influenced by financial resources required to incorporate new interventions and the resulting clinical and economic returns on those ...
T. Joseph Mattingly
semanticscholar   +1 more source

High Override Rate for Opioid Drug-allergy Interaction Alerts: Current Trends and Recommendations for Future

Medinfo, 2019
This study examined trends in drug-allergy interaction (DAI) alert overrides for opioid medications - the most commonly triggered alerts in the computerized provider order entry (CPOE).
M. Topaz, D. Seger, Kenneth H. Lai, Paige G. Wickner, F. Goss, Neil Dhopeshwarkar, F. Chang, D. Bates, Li Zhou   +8 more
semanticscholar   +1 more source

Protocols for drug allergy desensitization in children

Expert Review of Clinical Immunology, 2019
Introduction: When a drug hypersensitivity reaction is proven, desensitization protocols allow the reintroduction of the molecule in patients for whom such therapy is essential.
L. Diaferio, M. Giovannini, Evangéline Clark, R. Castagnoli, D. Caimmi   +4 more
semanticscholar   +1 more source

Drug allergy.

Allergy and Asthma Proceedings, 2019
Drug allergy describes clinical adverse reactions that are proved or presumed to be immunologically based. Allergic drug reactions do not resemble pharmacologic actions of the incriminated drug and may occur at fractions of what would be the therapeutic ...
P. Greenberger
semanticscholar   +1 more source

Enzalutamide and Apalutamide: In vitro Chemical Reactivity Studies and Activity in a Mouse Drug Allergy Model.

Chemical Research in Toxicology, 2019
Enzalutamide and apalutamide are two androgen receptor inhibitors approved for the treatment of castration-resistant prostate cancer (CRPC) and nonmetastatic castration-resistant prostate cancer (nmCRPC), respectively.
Changhua Ji, M. Guha, X. Zhu, Jessica Whritenour, Michelle D. Hemkens, Susanna Tse, Gregory S. Walker, E. Evans, Nasir K. Khan, Martin B. Finkelstein, Ernesto Callegari, R. Obach   +11 more
semanticscholar   +1 more source

Drug allergy in women.

Journal of Allergy and Clinical Immunology: In Practice, 2023
E. Lee, A. Copaescu, J. Trubiano, Elizabeth Jane Phillips, Anna R. Wolfson, Allison Ramsey   +5 more
semanticscholar   +1 more source

Drug Allergy Delabeling Programs: Recent Strategies and Targeted Populations

Clinical reviews in allergy and immunology, 2022
K. Anstey, L. Tsao, I. Otani
semanticscholar   +1 more source

FDA approves first drug for treatment of peanut allergy for children

, 2020
The first and only drug to treat peanut allergy recently received approval, giving the growing number of patients a new treatment option.
S. Jennings
semanticscholar   +1 more source

Skin Testing as a Biomarker in Drug Allergy.

Annals of Allergy, Asthma & Immunology, 2022
R. Saff
semanticscholar   +1 more source